Bibliografía del artículo
1. Taylor D, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 13:42-59, 1991.
2. Nilsson C, Sillen A, Eriksson L y col. Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal diseases. Infec Immun 71:6573-6581, 2003.
3. Marshall B. Helicobacter pylori. Am J Gastroenterol 89:116-127, 1994.
4. Foreman D y The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:359-362, 1993.
5. Wotherspoon A, Doglioni C, Diss T. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577, 1993.
6. Azuma T, Ito S, Sato F. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 82:1013-1018, 1998.
7. Kato I, Vivas J, Plummer M. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers 13:468-476, 2004.
8. Yang J, Wang T, Wang H, Kuo C, Wang J y Wang W. Genetic analysis of the cytotoxin associated gene and the vacuolating gene in Helicobacter pylori strains isolated from Taiwanese patients. Am J Gastroenterol 92:1316-1321, 1997.
9. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 113:321-333, 2004.
10. Covacci A, Censini S, Bugnoli M. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90:5791-5795, 1993.
11. Censini S, Lange C, Xiang Z y col. Cag, a pathogenicity island of Helicobacter pylori, encoded type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648-14653, 1996.
12. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 284:1328-1333, 1999.
13. Atherton JC, Cao P, Peek RM JR, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270:1771-1777, 1995.
14. Van Doorn LJ, Figueiredo C, Sanna R y col. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 36:2597-2603, 1993.
15. Mizushima T, Sugiyama T, Komatsu Y, Ishizuka J, Kato M, Asaka M. Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol 39:2463-2465, 2001.
16. Lai CH, Kuo CH, Chen YC y col. High prevalence of cagA and babA2 positive Helicobacter pylori clinical isolates in Taiwan. J Chin Med Assoc 40:3860-3862, 2000.
17. Yu J, Leung WK, Go MYY y col. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 51:480-484, 2002.
18. Boren T, Normark S, Falk P. Helicobacter pylori: molecular basis for host recognition and bacterial adherence. Trends Microbiol 2:221-228, 1994.
19. Gerhard M, Lehn N, Neumayer N y col. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 96:12778-12783, 1996.
20. Alves O A, Santos A, Becattini G J y col. (2003) babA2- and cagA-Positive Helicobacter pylori Strains Are Associated with Duodenal Ulcer and Gastric Carcinoma in Brazil. J Clin Microbiol 41, 3964-3966, .
21. Caner V, Yilmaz M, Yonetci N y col. H. pylori iceA alleles are disease-specific virulence factors. World J Gastroenterol 13:2581-2585, 2007.
22. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterol 128:833-848, 2005.
23. Arachchi HSJ, Kalra V, Lal B, y col. Prevalence of duodenal ulcer-promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian population. Helicobacter 12:591-597, 2007.
24. Argent RH, Burette A, Miendje Deyi VY, Atherton JC. The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin Infect Dis 45 :1204-1206, 2007.
25. Douraghi M, Mohammadi M, Oghalaie A, y col. DupA as a risk determinant in Helicobacter pylori infection. J Med Microbiol 57:554-562, 2008.
26. Rhead J, Letley DP, Marjan Mohammadi M y col. A New Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterol 133:926-936, 2007.
27. Zambon CF, Navaglia F, Basso D, Rugge M y Plebani M. Helicobacter pylori babA2, cagA, and s1vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 56:287-291, 2003.
28. Prado V. Enfermedades infecciosas emergentes: ¿Un problema nuevo? Rev Med Chile 124:7-10, 1996.
29. Martínez A, González C, Kawaguchi F y col. Helicobacter pylori: análisis de cagA y genotipificación de vacA en Chile. Detección de una cepa s2/m1. Rev Med Chile 129:1147-1153, 2001.
30. Faúndez G, Troncoso M, Figueroa G. CagA and vacA in strains of Helicobacter pylori from ulcer and non-ulcerative dyspepsia patients. BMC Gastroenterol 2:20, 2002.
31. Araya J, Anabalón L, Roa I y col. Relación de la genotipificación de Helicobacter pylori con la forma e intensidad de la gastritis en población adulta portadora de patología gástrica benigna. Rev Med Chile 132:1345-1354, 2004.
32. Working Party of the European Helicobacter pylori Study Group. Guidelines for clinical trials in Helicobacter pylori infection. Gut 41(Suppl 2):S3, 1997.
33. Mazurier S, Van de Giessen A, Heuvelman K, Wernars K. RAPD analysis of Campylobacter isolates: DNA fingerprinting without the need to purify DNA. Lett Appl Microbiol 14:260-262, 1992.
34. Ho SA, Hoyle JA, Lewis FA y col. Direct polymerase chain reaction test fordetection of Helicobacter pylon in humans and animals. J Clin Microbiol 29:2543-2549, 1991.
35. Van Doorn LJ, Figueiredo R, Sanna A y col. Clinical relevance of cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterol 115:58-66, 1998.
36. García A, Barra R, Delgado C y col. Genotipificación de aislados clínicos de Helicobacter pylori en base a genes asociados a virulencia cagA, vacA y babA2. Primer aislamiento de una cepa babA2 positiva. Rev Med Chile 134:981-988, 2006.
37. Navaglia F, Basso B y Plebani M. Touchdown PCR: a rapid method to genotype Helicobacter pylori infection. Clin Chim Acta 262:57-60, 1997.
38. Podzorski R, Podzorski D, Wuerth A y Tolia V. Analysis of the vacA, cagA, cagE, iceA and babA2 genes in Helicobacter pylori from sixty-one pediatric patient from the Midwestern united states. Diagnos Microbiol Infec Dis 46:83-88, 2003.
39. Hehenberger P, Gretechel S. Gastric Cancer. Lancet 362(9380):305, 2003.
40. Kim SY, Woo C, Lee YM y col. Genotyping cagA, vacA subtype, iceA and babA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseases. J Korean Med Sci 16:579-84, 2001.
41. Cittelly DMP, Huertas MG, Martínez JD y col. Helicobacter pylori genotypes in non atrophic gastritis, peptic ulcer disease, premalignant lesions and gastric cancer in Colombia. Rev Med Chile 130:985-989, 2002.
42. Debets-Ossenkopp YJ, Reyes G, Mulder J y col. Characteristics of clinical Helicobacter pylori strains from Ecuador. J Antimicrob Chemother 51:141-145, 2003.
43. Berroteran A, Perrone M, Correnti M y col. Detection of Helicobacter pylori DNA in the oral cavity and gastroduodenal system of Venezuelan population. J Med Microbiol 51:764-770, 2002.
44. Ramadan AAA, Collares GB, Nogueira E y col. IceA Genotypes of Helicobacter pylori Strains Isolated from Brazilian Children and Adults. J Clinl Microbiol 39:1746-1750, 2001.
45. Ito Y, Azuma T, Ito S. Sequence analysis and clinical significance of the iceA gene from Helicobacter pylori strains in Japan. J Clin Microbiol 38:483-488, 2000.
46. Yamaoka Y, Kodama T, Gutiérrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 37:2274-2279, 1999.
47. Blaser MJ, Berg DE. H pylori genetic diversity and risk of human disease. J Clin Invest 107:767-773, 2001.
48. Israel DA, Salama N, Arnold CN y col. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 107:611-620, 2001.